Caplin Point Laboratories

Caplin Point Laboratories Market capitalization

The The market capitalization of Caplin Point Laboratories (CAPLIPOINT.NS) as of Nov 5, 2026 is 125.36 B INR. In the previous year, The market capitalization was 125.36 B INR — a change of 0.00% (lower).

Market capitalization

125.36 BINR

YoY

0.00%

Last updated:

In 2025, Caplin Point Laboratories's market cap stood at 125.36 B INR, a 0.00% increase from the 125.36 B INR market cap in the previous year.

The Caplin Point Laboratories Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
125.36 B INR
Jan 1, 2019
125.36 B INR
Jan 1, 2020
125.36 B INR
Jan 1, 2021
125.36 B INR
Jan 1, 2022
125.36 B INR
Jan 1, 2023
125.36 B INR
Jan 1, 2024
125.36 B INR
Jan 1, 2025
125.36 B INR
The Caplin Point Laboratories Market capitalization history
YEARMarket capitalizationYoY
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR0.00%
125.36 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caplin Point Laboratories Stock analysis

What does Caplin Point Laboratories do? Caplin Point Laboratories Ltd manufactures and markets pharmaceutical products, including generic formulations and branded products, with a focus on tablets, dry syrups, soft gels, capsules, suppositories, liquid syrups, injectables, and topical formulations. The company exports these products to Latin America (LATAM), Southern Africa, Francophone Africa, the United States, and Europe, serving healthcare providers and distributors in these regions. Its principal manufacturing facility in Puducherry, India, supports production of pharmaceuticals for global markets, while R&D activities occur in Tamil Nadu, India. The company leverages subsidiaries Caplin Point Far East Limited and Caplin Steriles Limited to expand its operations and product reach. The firm generates revenue through the sale of its pharmaceutical products to international markets, with key segments including generic drugs and branded medicines. Products such as ophthalmic droppers, pre-mix bags, and lyophilized vials are marketed to healthcare systems and pharmacies in target regions. Manufacturing capabilities in Puducherry enable cost-effective production, while R&D in Tamil Nadu drives product innovation for global demand. Subsidiaries support distribution and specialized manufacturing, enhancing market penetration across diverse geographies. Caplin Point Laboratories Ltd targets healthcare providers, distributors, and pharmacies in LATAM, Southern Africa, Francophone Africa, the U.S., and Europe as its primary customers. The company’s product portfolio includes both generic and branded pharmaceuticals, with a focus on accessible, high-quality medicines. Manufacturing in Puducherry ensures efficient production, and R&D in Tamil Nadu supports continuous development of new formulations. Subsidiaries like Caplin Steriles Limited handle specialized sterile products, while Caplin Point Far East Limited aids in expanding presence in Asian markets. Caplin Point Laboratories is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Caplin Point Laboratories's Market Capitalization

Caplin Point Laboratories's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Caplin Point Laboratories's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Caplin Point Laboratories's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Caplin Point Laboratories’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Caplin Point Laboratories stock

The market capitalization of Caplin Point Laboratories is 125.36 B INR in 2025.

The market capitalization of Caplin Point Laboratories changed from 125.36 B INR to 125.36 B INR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Caplin Point Laboratories since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Caplin Point Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Caplin Point Laboratories

All Key Metrics — Caplin Point Laboratories